Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
about
Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics.Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HMechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 PocketTrimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathwaysSwapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infectionMutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 functionProspects for Foamy Viral Vector Anti-HIV Gene Therapy.A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
P2860
Q33313394-BA801D08-FCF1-4538-ACD9-13669F995C46Q33719511-5B30EA10-C8A4-4E6D-82CB-944C313DDC51Q34310045-8D90BD5E-AD93-48C4-8AA9-3940E2FE916DQ35599288-ECAE8F55-177C-4FDB-A9E2-C19890FAF58AQ35641194-DBE71231-4D16-4B56-A887-16F823F38001Q35868288-5296985C-C3F4-4925-B9BD-86BA0749D867Q36036157-5358C7A2-FCD8-436E-85D9-B8197336DA73Q37192248-D59E0CB4-5669-45D4-8736-1CE22CEB360CQ38076139-41F058FF-0CFC-420D-A330-05B88FA4CB3AQ38632078-F6A416BE-EAD2-428B-9554-DD94B13017F9Q50878341-9D239D0A-21A1-4081-B943-1A0EFB65870DQ54216810-3324C276-5229-41B0-A889-EA145B6514CE
P2860
Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human immunodeficiency virus ( ...... receptor activation of gp120.
@ast
Human immunodeficiency virus ( ...... receptor activation of gp120.
@en
type
label
Human immunodeficiency virus ( ...... receptor activation of gp120.
@ast
Human immunodeficiency virus ( ...... receptor activation of gp120.
@en
prefLabel
Human immunodeficiency virus ( ...... receptor activation of gp120.
@ast
Human immunodeficiency virus ( ...... receptor activation of gp120.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus ( ...... receptor activation of gp120.
@en
P2093
Carol D Weiss
Emmanuel Desmezieres
Keith Peden
Lev Sirota
Nidhi Gupta
Paul Wingfield
Russell Vassell
Zhongning Yang
P2860
P304
P356
10.1128/JVI.79.8.4774-4781.2005
P577
2005-04-01T00:00:00Z